Human Genome Epidemiology Literature Finder
Records 1 - 7 (of 7 Records) |
Query Trace: Carcinoma and BID[original query] |
---|
Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option. British journal of cancer 2014 Oct 111 (9): 1726-33. Meulendijks D, Dewit L, Tomasoa N B, van Tinteren H, Beijnen J H, Schellens J H M, Cats |
Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2. Gynecologic oncology 2017 9 147 (2): 267-275. Oza Amit M, Tinker Anna V, Oaknin Ana, Shapira-Frommer Ronnie, McNeish Iain A, Swisher Elizabeth M, Ray-Coquard Isabelle, Bell-McGuinn Katherine, Coleman Robert L, O'Malley David M, Leary Alexandra, Chen Lee-May, Provencher Diane, Ma Ling, Brenton James D, Konecny Gottfried E, Castro Cesar M, Giordano Heidi, Maloney Lara, Goble Sandra, Lin Kevin K, Sun James, Raponi Mitch, Rolfe Lindsey, Kristeleit Rebecca |
Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study. Cancer chemotherapy and pharmacology 2017 Mar . Tandia Mahamadou, Mhiri Asma, Paule Bernard, Saffroy Raphaël, Cailliez Valérie, Noé Gaëlle, Farinotti Robert, Bonhomme-Faivre Lauren |
Safety and pharmacokinetics of veliparib extended-release in patients with advanced solid tumors: a phase I study. Cancer medicine 2018 May . Werner Theresa L, Sachdev Jasgit, Swisher Elizabeth M, Gutierrez Martin, Kittaneh Muaiad, Stein Mark N, Xiong Hao, Dunbar Martin, Sullivan Danielle, Komarnitsky Philip, McKee Mark, Tan Antoinette |
Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study). ESMO open 2021 7 6 (4): 100212. Perez-Fidalgo J A, Cortés A, Guerra E, García Y, Iglesias M, Bohn Sarmiento U, Calvo García E, Manso Sánchez L, Santaballa A, Oaknin A, Redondo A, Rubio M J, González-Martín |
Identification of immune-related ferroptosis prognostic marker and in-depth bioinformatics exploration of multi-omics mechanisms in thyroid cancer. Frontiers in molecular biosciences 2022 9 9 961450. Fan Xin, Xie Fei, Zhang Lingling, Tong Chang, Zhang Zhiyu |
Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers. The oncologist 2022 5 . Le Xiuning, Baik Christina, Bauman Jessica, Gilbert Jill, Brose Marcia S, Grilley-Olson Juneko E, Patil Tejas, McDermott Ray, Raez Luis E, Johnson Jennifer M, Shen Lin, Tahara Makoto, Ho Alan L, Norenberg Ricarda, Dima Laura, Brega Nicoletta, Drilon Alexander, Hong David |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: